Alfasigma is a pharmaceutical company that has accepted an important challenge.
Alfasigma has raised $175.8M in total funding. The most recent round was Debt Financing. The last funding was announced in July 2025.
Alfasigma's investors include European Investment Bank.
Alfasigma is headquartered in Bologna, Italy.
Alfasigma is a pharmaceutical company that has accepted an important challenge.
Alfasigma is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alfasigma — Funding & Investors." VCBacked, July 8, 2025, https://www.vcbacked.co/company/alfasigma. Accessed August 14, 2026.
VCBacked. (2025). Alfasigma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/alfasigma
{{cite web |title=Alfasigma — Funding & Investors |url=https://www.vcbacked.co/company/alfasigma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated